Salt Lake City, UT, July 08, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives today announced the acquisition of ...
The program originated from a joint venture with Rallybio, with Recursion leading the precision design of REV102. The Recursion OS - an integrated AI/experimental platform - was used to optimize for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results